Colon Cancer ED

  • Detection of early colorectal cancer & precancerous lesions

0 People watching this product now!
  • Sensitivity 84.45%
  • Specificity 94.22%
  • A blood-based test for diagnosis of colorectal cancer by detecting a combination of proprietary epigenomics DNA methylation biomarkers
  • Detection of early colorectal cancer & precancerous lesions.
  • Patients with a positive test result should be referred for diagnostic
  • Patients with a negative test result should discuss with their doctor when they need to be tested again
  • Follow-up and monitoring
  • Prognostic evaluation
  • Therapeutic assessment
  • Male & female aged 40 and above
  • Been diagnosed with type II diabetes
  • A history of colorectal cancer, adenomas, other related cancers, or a relevant familial (hereditary) cancer syndrome
  • Anorectal symptoms more than two weeks
  • A history of benign polyps in the colon or rectum or related cancers, like (IBD), chronic ulcerative colitis (CUC), etc.
  • Habits of a high-fat diet, smoking or drinking

Related Products

Recently Viewed Products